These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19781516)

  • 1. Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
    Peters S
    Clin Cornerstone; 2009; 9(3):50-3. PubMed ID: 19781516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance.
    Cummings RH
    J Allergy Clin Immunol; 1999 Dec; 104(6):S230-6. PubMed ID: 10588980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moisture transport into chlorofluorocarbon-free metered dose inhalers.
    Williams G
    J Allergy Clin Immunol; 1999 Dec; 104(6):S227-9. PubMed ID: 10588979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
    Hartung TK; Allbutt H; Dewar M; Innes JA; Crompton GK
    Respiration; 2002; 69(4):314-9. PubMed ID: 12169743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs.
    Nogami-Itoh M; Yakuo I; Hammerbeck DM; Miller RL; Takeyama K
    Pharm Res; 1997 Feb; 14(2):208-12. PubMed ID: 9090711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models.
    Cole CH; Mitchell JP; Foley MP; Nagel MW
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F417-8. PubMed ID: 15321960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible replacements for CFC-propelled metered-dose inhalers.
    Dalby RN
    Med Device Technol; 1991 May; 2(4):21-5. PubMed ID: 10149436
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Dose proportionality of fluticosone proportionate hydrofluoroalkane pressurized metered dose inhalers (pMDIS) and comparability with chlorofluorocarbon pMDIS.
    Lipworth BJ
    Respir Med; 2001 Feb; 95(2):160-3. PubMed ID: 11217914
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 16. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counseling about chlorofluorocarbon-free inhalers.
    Breitigan JM
    Am J Health Syst Pharm; 1998 Feb; 55(3):226-7. PubMed ID: 9492253
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers.
    Ganderton D; Lewis D; Davies R; Meakin B; Brambilla G; Church T
    Respir Med; 2002 Aug; 96 Suppl D():S3-8. PubMed ID: 12201079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines.
    Ayres JG; Frost CD; Holmes WF; Williams DR; Ward SM
    BMJ; 1998 Oct; 317(7163):926-30. PubMed ID: 9756813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorofluorocarbon to hydrofluoroalkane formulations: an industry perspective.
    Atkins P
    J Allergy Clin Immunol; 1999 Dec; 104(6):S268-70. PubMed ID: 10588988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.